|
Aug 9
|
Amphastar Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations
|
|
Aug 9
|
Amphastar Pharmaceuticals Inc (AMPH) Q2 2025 Earnings Call Highlights: Strong Vaccine Sales and ...
|
|
Aug 8
|
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?
|
|
Aug 8
|
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6%
|
|
Aug 7
|
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Aug 7
|
Amphastar: Q2 Earnings Snapshot
|
|
Aug 7
|
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
|
|
Aug 6
|
Amphastar Pharmaceuticals (AMPH) Reports Q2: Everything You Need To Know Ahead Of Earnings
|
|
Aug 5
|
Investors in Amphastar Pharmaceuticals (NASDAQ:AMPH) have unfortunately lost 47% over the last year
|
|
Jul 31
|
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 29
|
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
|
|
Jul 23
|
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
|
|
Jul 23
|
What Makes Amphastar (AMPH) a New Buy Stock
|
|
Jul 23
|
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?
|
|
Jul 23
|
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 Weeks
|
|
Jul 18
|
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know
|
|
Jun 11
|
AMPH Q1 Earnings Call: Product Mix Shift and Margin Pressures Highlight Competitive Challenges
|
|
Jun 11
|
3 Russell 2000 Stocks with Questionable Fundamentals
|
|
May 9
|
Amphastar Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations
|
|
May 9
|
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
|